Ameritas Investment Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.6K | Hold |
4,281
| – | – | ﹤0.01% | 2403 |
|
|
2025
Q4 | $37.8K | Hold |
4,281
| – | – | ﹤0.01% | 2314 |
|
|
2025
Q3 | $21.4K | Hold |
4,281
| – | – | ﹤0.01% | 2625 |
|
|
2025
Q2 | $20.2K | Hold |
4,281
| – | – | ﹤0.01% | 2658 |
|
|
2025
Q1 | $19.6K | Hold |
4,281
| – | – | ﹤0.01% | 2565 |
|
|
2024
Q4 | $20.5K | Hold |
4,281
| – | – | ﹤0.01% | 2624 |
|
|
2024
Q3 | $20.1K | Hold |
4,281
| – | – | ﹤0.01% | 2654 |
|
|
2024
Q2 | $24.2K | Hold |
4,281
| – | – | ﹤0.01% | 2534 |
|
|
2024
Q1 | $17.6K | Hold |
4,281
| – | – | ﹤0.01% | 2607 |
|
|
2023
Q4 | $18.1K | Hold |
4,281
| – | – | ﹤0.01% | 2621 |
|
|
2023
Q3 | $18.5K | Hold |
4,281
| – | – | ﹤0.01% | 2572 |
|
|
2023
Q2 | $28.2K | Hold |
4,281
| – | – | ﹤0.01% | 2369 |
|
|
2023
Q1 | $29.1K | Hold |
4,281
| – | – | ﹤0.01% | 2291 |
|
|
2022
Q4 | $32.8K | Hold |
4,281
| – | – | ﹤0.01% | 2308 |
|
|
2022
Q3 | $42K | Hold |
4,281
| – | – | ﹤0.01% | 2118 |
|
|
2022
Q2 | $46K | Hold |
4,281
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q1 | $48K | Hold |
4,281
| – | – | ﹤0.01% | 2085 |
|
|
2021
Q4 | $67K | Hold |
4,281
| – | – | ﹤0.01% | 1943 |
|
|
2021
Q3 | $73K | Hold |
4,281
| – | – | ﹤0.01% | 1897 |
|
|
2021
Q2 | $92K | Hold |
4,281
| – | – | ﹤0.01% | 1774 |
|
|
2021
Q1 | $64K | Hold |
4,281
| – | – | ﹤0.01% | 1938 |
|
|
2020
Q4 | $56K | Hold |
4,281
| – | – | ﹤0.01% | 1916 |
|
|
2020
Q3 | $41K | Hold |
4,281
| – | – | ﹤0.01% | 1963 |
|
|
2020
Q2 | $49K | Hold |
4,281
| – | – | ﹤0.01% | 1840 |
|
|
2020
Q1 | $44K | Hold |
4,281
| – | – | ﹤0.01% | 1743 |
|
|
2019
Q4 | $70K | Hold |
4,281
| – | – | ﹤0.01% | 1719 |
|
|
2019
Q3 | $57K | Hold |
4,281
| – | – | ﹤0.01% | 1814 |
|
|
2019
Q2 | $60K | Hold |
4,281
| – | – | ﹤0.01% | 1822 |
|
|
2019
Q1 | $79K | Hold |
4,281
| – | – | ﹤0.01% | 1626 |
|
|
2018
Q4 | $112K | Hold |
4,281
| – | – | 0.01% | 1300 |
|
|
2018
Q3 | $98K | Buy |
4,281
+415
| +11% | +$8.47K | ﹤0.01% | 1588 |
|
|
2018
Q2 | $74K | Hold |
3,866
| – | – | ﹤0.01% | 1748 |
|
|
2018
Q1 | $65K | Hold |
3,866
| – | – | ﹤0.01% | 1764 |
|
|
2017
Q4 | $59K | Hold |
3,866
| – | – | ﹤0.01% | 1841 |
|
|
2017
Q3 | $66K | Hold |
3,866
| – | – | ﹤0.01% | 1706 |
|
|
2017
Q2 | $63K | Buy |
3,866
+1,011
| +35% | +$14.6K | ﹤0.01% | 1752 |
|
|
2017
Q1 | $40K | Buy |
+2,855
| New | +$40.7K | ﹤0.01% | 1991 |
|
Other funds holding VNDA
ACM
VCM
Ameritas Investment Partners's VNDA Position: Q1 2026 in Review
Ameritas Investment Partners held its Vanda Pharmaceuticals (VNDA) position steady in Q1 2026 at 4,281 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2403.
Ameritas Investment Partners first reported a position in VNDA in Q1 2017 and has held it in 37 quarters since. The position peaked at $112K in Q4 2018. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- Ameritas Investment Partners held 4,281 shares of Vanda Pharmaceuticals worth $29.6K as of Q1 2026.
- Ameritas Investment Partners left its Vanda Pharmaceuticals share count unchanged in Q1 2026.
- Vanda Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2403 holding.
- Ameritas Investment Partners first reported a position in Vanda Pharmaceuticals in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Vanda Pharmaceuticals position peaked at $112K in Q4 2018.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.